RAMUNDO, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 2.693
EU - Europa 773
AS - Asia 624
SA - Sud America 70
AF - Africa 12
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.177
Nazione #
US - Stati Uniti d'America 2.664
SG - Singapore 309
IT - Italia 269
SE - Svezia 154
CN - Cina 128
IN - India 119
BE - Belgio 63
RU - Federazione Russa 59
DE - Germania 55
BR - Brasile 42
GB - Regno Unito 35
RO - Romania 23
CA - Canada 22
AR - Argentina 21
FI - Finlandia 18
FR - Francia 18
UA - Ucraina 16
ID - Indonesia 14
NL - Olanda 14
TR - Turchia 12
BG - Bulgaria 11
CH - Svizzera 11
HK - Hong Kong 9
JP - Giappone 9
KR - Corea 9
AT - Austria 6
IE - Irlanda 6
MX - Messico 6
ZA - Sudafrica 5
DK - Danimarca 4
IQ - Iraq 4
TG - Togo 4
LT - Lituania 3
AU - Australia 2
CL - Cile 2
CO - Colombia 2
EC - Ecuador 2
EE - Estonia 2
ES - Italia 2
EU - Europa 2
GR - Grecia 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
DZ - Algeria 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
PA - Panama 1
PL - Polonia 1
SC - Seychelles 1
TW - Taiwan 1
UG - Uganda 1
UZ - Uzbekistan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 4.177
Città #
Fairfield 510
Woodbridge 211
Ashburn 210
Seattle 206
Chandler 182
Wilmington 180
Houston 174
Cambridge 167
Singapore 124
Rome 97
Princeton 93
Ann Arbor 77
Beijing 63
Brussels 62
Millbury 52
Dearborn 45
Plano 40
Cosenza 37
Santa Clara 31
San Diego 28
New York 22
San Paolo di Civitate 22
Federal 21
Lawrence 18
Falls Church 17
Helsinki 16
Boston 15
Jakarta 14
Moscow 14
Toronto 13
Andover 12
Istanbul 12
Norwalk 12
Southend 12
Falkenstein 11
London 11
Sofia 11
Zurich 11
Boardman 9
Fremont 9
Hong Kong 9
Milan 9
Ottawa 9
Amsterdam 7
Council Bluffs 7
Grafing 7
Legnano 7
Los Angeles 7
Cagliari 6
Dublin 6
Jinan 6
Nanjing 6
Nuremberg 6
Tokyo 6
Bremen 5
Kunming 5
Paris 5
Redwood City 5
Yubileyny 5
Des Moines 4
Edinburgh 4
Jacksonville 4
Lomé 4
Munich 4
Basrah 3
Binasco 3
Cerignola 3
Dongjak-gu 3
Frankfurt am Main 3
Hangzhou 3
Hefei 3
Johannesburg 3
Mexico City 3
Nanchang 3
Athens 2
Bühl 2
Campinas 2
Chennai 2
Chicago 2
Gothenburg 2
Guangzhou 2
Guayaquil 2
Latina 2
Manfredonia 2
Mannheim 2
Muizenberg 2
Nettuno 2
Niigata 2
Phoenix 2
Pune 2
Sorocaba 2
Tallinn 2
Trumbull 2
Almaty 1
Amatrice 1
Amontada 1
Aracaju 1
Arzano 1
Ascurra 1
Assis 1
Totale 3.089
Nome #
Lack of association between obesity and aggressiveness of differentiated thyroid cancer 114
Computer-aided diagnostic system for thyroid nodule sonographic evaluation outperforms the specificity of less experienced examiners 114
Reducing the number of unnecessary thyroid biopsies while improving diagnostic accuracy: towards the "right" TIRADS 111
Is thyroid nodule location associated with malignancy risk? 110
Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissue 110
Sonographic presentation of metastases to the thyroid gland: a case-series 109
Correction to. Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma 107
Selective use of radioactive iodine therapy for papillary thyroid cancers with low or lower-intermediate recurrence risk 106
Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas 105
Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments 103
Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound 102
Sonographically estimated risks of malignancy for thyroid nodules computed with five standard classification systems. Changes over time and their relation to malignancy 101
Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma 101
A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal 92
Taller-than-wide shape: a new definition improves the specificity of TIRADS systems 92
Cancer care during COVID-19 era: the quality of life of patients with thyroid malignancies 90
Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients 87
Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients 86
Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels 85
Diagnostic performance of neck ultrasonography in the preoperative evaluation for extrathyroidal extension of suspicious thyroid nodules 83
Diagnosis and Differential Diagnosis of Medullary Thyroid Cancer 82
Limitations of Chromogranin A in clinical practice 82
Thyroid hormone therapy in differentiated thyroid cancer 82
Is it worth suppressing TSH in low- and intermediate-risk papillary thyroid cancer patients before the first disease assessment? 81
Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism 80
Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases 80
Hepatic arterial embolization in patients with neuroendocrine tumors 80
Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients 79
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 78
CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR 77
Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation 77
Hereditary neuroendocrine tumor syndromes 73
Loss of function SETD2 mutations in poorly differentiated metastases from two Hürthle cell carcinomas of the thyroid 73
Anticoagulant therapy in oncologic patients undergoing venous stenting for superior vena cava syndrome and other interventional procedures 72
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study 72
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET 72
Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules 72
null 70
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 69
Targeted therapy with kinase inhibitors in aggressive endocrine tumors 68
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours 67
Genetic-clinical profile of subjects with apparently sporadic extra-adrenal paragangliomas 66
Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1) 61
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication 60
Pituitary function and morphology in Fabry disease 60
Prediction of response to vemurafenib in BRAF V600E mutant cancers based on a network approach 53
Contemporary thyroid nodule evaluation and management 53
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study 52
Predictive factors of response to mTOR inhibitors in neuroendocrine tumours 51
Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy? 50
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses 49
Computer-aided diagnostic system for thyroid nodule sonographic evaluation outperforms the specificity of less experienced examiners 49
Sonographic risk stratification systems for thyroid nodules as rule-out tests in older adults 47
Fournier's gangrene during lenvatinib treatment: a case report 43
Nuove frontiere nel carcinoma midollare della tiroide: identificazione di nuovi biomarkers diagnostici 41
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 38
Thyroid function in Fabry disease before and after enzyme replacement therapy 36
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1 32
Tumor Related- and Non-tumor-Related Diarrhea in a Medullary Thyroid Cancer Patient 30
null 26
null 25
A Young Patient with Intrathyroidal Papillary Thyroid Cancer and Family History of Differentiated Thyroid Cancer 25
Variazioni epidemiologiche delle neoplasie tiroidee nel tempo: ruolo della nutrizione iodica 24
Thyroid diseases in elderly 10
Prognosis of patients with differentiated thyroid carcinomas having a preoperative cytological report of indeterminate at low or high risk. A multicenter study 6
Totale 4.581
Categoria #
all - tutte 13.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.421


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020424 0 0 0 0 0 0 0 0 131 169 58 66
2020/2021611 45 72 18 26 11 45 19 60 84 79 34 118
2021/2022734 7 40 61 44 86 33 12 77 67 38 135 134
2022/2023648 143 87 33 80 82 64 11 48 60 9 27 4
2023/2024267 13 48 4 36 18 31 7 22 0 37 35 16
2024/2025695 8 13 105 76 46 54 73 59 261 0 0 0
Totale 4.581